Press release
Enterobacteriaceae Infection Drug: A Guide to Understanding the Process
MARKET INTRODUCTIONEnterobacteriaceae are a large family of different types of germs (bacteria) that commonly cause infections in healthcare settings. Examples of germs in the Enterobacteriaceae family include Escherichia coli (E. coli) and Klebsiella pneumoniae.
MARKET DYNAMICS
Rising prevalence of Enterobacteriaceae infectious diseases, For instance, in 2021, CRE caused an estimated 13,100 infections in hospitalized patients, and 1,100 estimated deaths in the United States increasing modes of spread of the infectious disease and a lack of cleanliness are the driving factors. However, the major factor which will restrain the market growth rapid resistance to drugs currently available for enterobacter infections. Furthermore, launch of new antibiotics with activity against carbapenem-resistant Enterobacteriaceae (CRE) will offer lucrative opportunities in the market.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00008464?utm_source=OpenPR&utm_medium=10852
Enterobacteriaceae Infection Drug Market: Competitive Landscape and Key Developments:
1. Genentech, Inc.
2. Allergan
3. Novartis AG
4. Pfizer Inc.
5. Nymox Pharmaceutical Corporation
6. Sequoia Sciences, Inc.
7. Phico Therapeutics Ltd.
8. Melinta Therapeutics, Inc.
9. Spero Therapeutics
10. Cipla USA, Inc.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enterobacteriaceae Infection Drug: A Guide to Understanding the Process here
News-ID: 3870165 • Views: …
More Releases from The Insight Partners

Top Aluminum Casting Manufacturers Analysis 2025
Aluminum casting is a manufacturing process where molten aluminum is poured into molds to create various shapes and parts. It's widely used in industries like automotive, aerospace, and construction due to its lightweight, durable, and corrosion-resistant properties.
Get PDF: @ https://www.theinsightpartners.com/sample/TIPRE00009480/?utm_source=OpenPR&utm_medium=10864
The Aluminum Casting Market is expected to register a CAGR of 7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million…

Traumatic Brain Injury Diagnostics Equipment Top Companies Regional and Data Ana …
A TBI may be open (penetrating) or closed (non-penetrating). A penetrating TBI occurs when a physical, external forces affect the brain and an object enters the brain tissue.
Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00018814/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Traumatic Brain Injury Diagnostics Equipment Market are:
• GE HealthCare Technologies Inc
• Elekta AB
• Integra LifeSciences Holdings Corp
• Natus Medical Inc
• Raumedic AG
• BrainScope Co Inc
• Luciole Medical AG
• Soterix Medical Inc
• Medtronic Plc
Contact Us:
If you have any queries about this report or…
![A Complete Guide to Logistics Services [PDF E-Book]](https://cdn.open-pr.com/L/3/L327971711_g.jpg)
A Complete Guide to Logistics Services [PDF E-Book]
Logistics services are essential for businesses that involve the transportation of goods from one place to other, and to avoid the complications related to the process, various SMEs and large organizations are adopting logistics services. With rapid developments in technologies, several small & medium, and large enterprises are opting for logistics services, which allows them to shift their focus on core competencies, company restructuring, and cost reduction. Based on organization…
Electric Vehicle Market Dynamics, Growth, Trends, and Opportunities 2031
The electric vehicle market is expected to reach US$ 618.75 billion by 2031 from US$ 386.11 billion in 2024; it is expected to record a CAGR of 14.5% during the forecast period
The EV market is expanding beyond the traditional passenger vehicle to various other segments, such as commercial vehicles (electric trucks, buses, delivery vans) and luxury electric vehicles. Increasingly, manufacturers are emphasizing the provision of electric models across a wider…
More Releases for Enterobacteriaceae
Enterobacteriaceae Infection Drug Market Trends, Research, Analysis & Forecast 2 …
The latest Enterobacteriaceae Infection Drug Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Enterobacteriaceae Infection…
Enterobacteriaceae Infection Drug Market Detailed Analysis of Current Industry F …
Complete study of the global Enterobacteriaceae Infection Drug market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Enterobacteriaceae Infection Drug industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They…
Enterobacteriaceae Infection Drug Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Enterobacteriaceae Infection Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Enterobacteriaceae Infection Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
Carbapenem-resistant Enterobacteriaceae Testing Market to Partake Significant De …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii. These…
Carbapenem-resistant Enterobacteriaceae Testing Market Analysis, Segments, Growt …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
These gram-negative…
Carbapenem-resistant Enterobacteriaceae Testing Market Projected to Witness Vigo …
Carbapenem-resistant Enterobacteriaceae Testing Market Overview
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea testing market have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing market is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli,…